EY Center for Health Equity
We create solutions that advance health equity for all and drive cross-sector enablement of health equity, improved health outcomes and long-term enterprise value — not only because it’s the right thing to do, but also because it makes good business sense.
How companies can take action to improve health equity
Dr. Susan Garfield, EY’s Chief Public Health Officer, discusses the changing approach to vaccines and boosters with the spread of Omicron variant and how employers can adapt. In light of more affordable health care needed than ever, she also covers how companies can take action to address health inequity.
While many health care stakeholders strive to provide universal care and resources for all, inequity continues to run deep within the health care system.
Racial and ethnic health disparities$93b
Estimated total annual cost of racial and ethnic health disparities in the US is $93 billion in excess medical care costs.
Estimated total annual cost of racial and ethnic health disparities in the US is $42 billion in untapped productivity
Source: “The Business Case for Racial Equity,” Altarum website, https://altarum.org/sites/default/files/uploaded-publication-files/WKKellogg_Business-Case-Racial-Equity_National-Report_2018.pdf, accessed 21 September 2021.
Only when the challenges of inequity are identified can we begin to achieve true health equity.
How Ernst & Young LLP can help
Whether your organization is in the early stages of developing a health equity strategy or currently taking action on key initiatives, our framework can be customized to help drive your health equity agenda. This approach is market-tested, validated and focused on driving measurable impacts to both health outcomes and business metrics. The framework focuses on the four drivers of value creation: consumer, human, societal and infrastructure value.
Health equity is the state in which health outcomes and health care costs are not determined by race, ethnicity or socioeconomic status.
We apply this framework to four core areas:
From eliminating care variation within vulnerable populations to improving clinical trial diversity and creating impactful community partnerships designed to proactively close gaps in the care continuum, our framework and areas of focus have broad, cross-sector application.
Our proprietary tools assess key stakeholders’ performance along customized health equity-related benchmarks and metrics, determine market dynamics that inform business decisions and strategic planning, and leverage “smart health” analytics for unique data insights.
Successful health equity strategies will focus on long-term value and eliminate health disparities in vulnerable communities. The benefits of our strategic health equity approach include:
- Equitable patient outcomes
- Affordable customer pricing
- Increased patient trust for health care industry
- Greater diversity, equity and inclusion
- Enhanced workforce equity
- Reduced systemic bias
- Improved health literacy
Our health equity insights and solutions can enable you to:
- Transform your approach to data management to enhance the employee and patient experience
- Leverage metrics to understand your patients’ vulnerability to health disparities in the market
- Drive greater access to quality health care for underserved communities
- Attract, recruit and retain diverse talent to improve cultural competency in both patient and workforce interactions
- Establish and grow patient-centered care practices to improve outcomes, reduce health disparities and grow revenue
Our EY Center for Health Equity team
The EY Center for Health Equity has been established with a dedication to helping EY clients, industry stakeholders and society at large to develop and implement leading solutions that promote and deliver on health equity. EY Americas Chief Medical Officer and seasoned health equity practitioner Yele Aluko, MD, MBA, serves as director of the Center for Health Equity, with Susan Garfield, DrPH, serving as co-director.
Our diverse team is composed of health equity champions with deep experience and specific passion for the elimination of health disparities in the US health-corporate industry. Our experience spans health care, public health and life sciences; corporate strategy and transactions; AI; advanced analytics; and diversity, equity and inclusion.